产品名称 | NebuSelect™ Recombinant Human MOG/Myelin Oligodendrocyte Glycoprotein, His-tag |
---|---|
目录号 | NBL-242293 |
别名 | MOG/Myelin Oligodendrocyte Glycoprotein; MOG; MGC26137; MOG Ig-AluB; MOGIG2; BTN6; BTNL11; NRCLP7 |
外观 | see COA |
分子量 | Gly30-Gly154 |
CAS | N/A |
溶解度 | Water Soluble |
存储条件 | Short term 4℃; Long term -20℃. |
保存时间 | 2 years |
备注1 | Q16653 |
备注2 |
目录号 | 规格 | 价格 | 库存状态 | |
NBL-242293-100ug | 100ug | Inquire | Inquire | |
NBL-242293-1mg | 1mg | Inquire | Inquire | |
NBL-242293-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Human MOG/Myelin Oligodendrocyte Glycoprotein, His-tag
Catalog#:
NBL-242293
Description:
NebuSelect™ Recombinant Human MOG/Myelin Oligodendrocyte Glycoprotein, His-tag(Cat#NBL-242293) is expressed in HEK293 with His tag at the C-Terminus.It contains Gly30-Gly154.
Species:
Human
Expression System:
HEK293
Molecular Weight:
The protein has a predicted MW of 15.4 kDa. Due to glycosylation, the protein migrates to 20-23 kDa based on Bis-Tris PAGE result.
Target Name:
MOG/Myelin Oligodendrocyte Glycoprotein; MOG; MGC26137; MOG Ig-AluB; MOGIG2; BTN6; BTNL11; NRCLP7
Target Information:
Myelin oligodendrocyte glycoprotein (MOG) antibody disease is a rare autoimmune disorder with antibodies against the MOG predominantly involving the optic nerve and spinal cord leading to vision loss and paralysis. When MOG antibody disease involves the brain, the phenotype is similar to acute disseminated encephalomyelitis (ADEM).
Amino Acid Sequence:
Gly30-Gly154
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.